US1793723A - Medicated tobacco and process of making same - Google Patents
Medicated tobacco and process of making same Download PDFInfo
- Publication number
- US1793723A US1793723A US354708A US35470829A US1793723A US 1793723 A US1793723 A US 1793723A US 354708 A US354708 A US 354708A US 35470829 A US35470829 A US 35470829A US 1793723 A US1793723 A US 1793723A
- Authority
- US
- United States
- Prior art keywords
- tobacco
- iodine
- medicated
- making same
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000208125 Nicotiana Species 0.000 title description 28
- 235000002637 Nicotiana tabacum Nutrition 0.000 title description 28
- 238000000034 method Methods 0.000 title description 10
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 24
- 239000011630 iodine Substances 0.000 description 24
- 229910052740 iodine Inorganic materials 0.000 description 24
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 2
- 235000019506 cigar Nutrition 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 208000021510 thyroid gland disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/287—Treatment of tobacco products or tobacco substitutes by chemical substances by inorganic substances only
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
Definitions
- This invention relates to medicated tobacco and process ofmaking the same, and it comprises more specifically the treatment of smoking tobacco for pipes, cigarettes or cigars with iodine, whereby the iodine may be effectively administered in the small amounts necessary for body metabolism and for the treatment of various infections of the respiratory organs, as well as thyroid disease, blood and glandular diseases, and numerous others.
- Iodine has long been recognized not only as a powerful antiseptic, but also as having great eificacy in the treatment of numerous diseases. Tobacco lends itself extremely well as a vehicle for the administration of iodine to the human body, since, because of its heat in burning, the iodine which it carries is volatilized, and in its volatilized condition is inhaled.
- pure iodine crystals are heated in aclosed chamher to a temperature of from 110 C. to 120 C., this temperature being suflicientlyhigh to practically completely vaporize the iodine.
- the pure iodine vapor is then conducted to an air tight chamber containing the tobacco, which has been previously prepared by any well known method for use in pipes, cigarettes or cigars.
- the temperature of this second chamber is maintained at, or slightly below, room temperature (approximately 70 F.), thus permitting the iodine vapor to return to a crystal state, and in such state to be deposited upon the tobacco.
- the tobacco, now containing the iodine is removed from the treating chamber and the iodine content determined by the iodine starch test.
- the treated tobacco is then blended with untreated tobacco until the desired blend and iodine content is obtained.
- An alternative process consists in immersing the tobacco ina pure grain alcohol solution, which contains 25% iodine and 15% potassium iodide. The tobacco is allowed to remain in this solution for from twenty-four to seventy-two hours at slightly below room temperature, that is, somewhat under 70 F.
- the excess solution is drained off and the tobacco is dried for several days at a temperature low enough to prevent volatilization of the iodine which is intimately associated with it in crystalline form.
- the alcohol is, thus, completely evaporated, leavin the iodine deposited in the tobacco.
- the iodine content is next determined by the iodine starch test and the treated tobacco is then blended with untreated tobacco to obtain the desired blend and percentage of iodine.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Patented Feb. 24, 1931 PATENT OFFICE FRANK I. STRIGKLER, OF LOUISVILLE, KENTUCKY MEDICATEID TOBACCO AND PROCESS OF MAKING SAME Io Drawing.
This invention relates to medicated tobacco and process ofmaking the same, and it comprises more specifically the treatment of smoking tobacco for pipes, cigarettes or cigars with iodine, whereby the iodine may be effectively administered in the small amounts necessary for body metabolism and for the treatment of various infections of the respiratory organs, as well as thyroid disease, blood and glandular diseases, and numerous others.
Iodine has long been recognized not only as a powerful antiseptic, but also as having great eificacy in the treatment of numerous diseases. Tobacco lends itself extremely well as a vehicle for the administration of iodine to the human body, since, because of its heat in burning, the iodine which it carries is volatilized, and in its volatilized condition is inhaled.
In accordance with my invention, pure iodine crystals are heated in aclosed chamher to a temperature of from 110 C. to 120 C., this temperature being suflicientlyhigh to practically completely vaporize the iodine. The pure iodine vapor is then conducted to an air tight chamber containing the tobacco, which has been previously prepared by any well known method for use in pipes, cigarettes or cigars. The temperature of this second chamber is maintained at, or slightly below, room temperature (approximately 70 F.), thus permitting the iodine vapor to return to a crystal state, and in such state to be deposited upon the tobacco. After an exposure of from twenty-four to seventytwo hours the tobacco, now containing the iodine, is removed from the treating chamber and the iodine content determined by the iodine starch test. The treated tobacco is then blended with untreated tobacco until the desired blend and iodine content is obtained.
An alternative process consists in immersing the tobacco ina pure grain alcohol solution, which contains 25% iodine and 15% potassium iodide. The tobacco is allowed to remain in this solution for from twenty-four to seventy-two hours at slightly below room temperature, that is, somewhat under 70 F.
Application filed April 12,
1929. Serial No. 354,708.
At the end of this time the excess solution is drained off and the tobacco is dried for several days at a temperature low enough to prevent volatilization of the iodine which is intimately associated with it in crystalline form. The alcohol is, thus, completely evaporated, leavin the iodine deposited in the tobacco. As 1n the process first described, the iodine content is next determined by the iodine starch test and the treated tobacco is then blended with untreated tobacco to obtain the desired blend and percentage of iodine.
Having described my invention, what I claim is: i.
1. The process of medicating tobacco with iodine which consists in first converting iodine to a fluid state and, in such state, bringing it into contact with tobacco to be treated, and finally in crystallizing the iodine while in contact with the tobacco to thereby intimately associate it therewith.
2. The process of medicating tobacco with iodine, which consists in first volatilizing iodine crystals b heat to convert the iodine into vapors, an finally, in the presence of tobacco to be treated, re-crystallizing the iodine by reducing the temperature of its vapors, to deposit it upon the tobacco and thereby medicate it.
3. The process of medicating tobacco with iodine, which consists in heating iodine crystals in a closed chamber to the point of volatilization of the iodine, conveying the vapors so produced to a second chamber containing tobacco to be treated, and maintaining the contact of iodine and tobacco in said second chamber for from twenty-four to seventytwo hours at a lower temperature, thereby to cause re-crystallizationof the iodine.
- 4. The process of medicating tobacco with iodine, which consists in preparing a solution of pure grain alcohol and iodine, soaking tobacco in such solution at slightly below room temperature, draining off the excess of the solution, and finally drying the treated tobacco at slightly below room temperature to prevent volatilization of its iodine content.
In testimony whereof I allix my si nature.
FRANK r. s'rmoK'tER.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US354708A US1793723A (en) | 1929-04-12 | 1929-04-12 | Medicated tobacco and process of making same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US354708A US1793723A (en) | 1929-04-12 | 1929-04-12 | Medicated tobacco and process of making same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US1793723A true US1793723A (en) | 1931-02-24 |
Family
ID=23394579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US354708A Expired - Lifetime US1793723A (en) | 1929-04-12 | 1929-04-12 | Medicated tobacco and process of making same |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US1793723A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2418296A (en) * | 1944-04-17 | 1947-04-01 | Sarah S Frederickson | Medicated cigarette |
-
1929
- 1929-04-12 US US354708A patent/US1793723A/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2418296A (en) * | 1944-04-17 | 1947-04-01 | Sarah S Frederickson | Medicated cigarette |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2114281A (en) | Tobacco and process of treating same | |
| US1793723A (en) | Medicated tobacco and process of making same | |
| Janiger et al. | Nicotiana an hallucinogen? | |
| JP2019187395A (en) | Electronic cigarette liquid | |
| KR900007855B1 (en) | Process for making cigarettes from leaf of eucommia ulmoides oliver | |
| US729218A (en) | Process of improving tobacco. | |
| US3643668A (en) | Oxidized cellulose smoking product composition | |
| DE1065767B (en) | Process for mentholizing tobacco and manufacturing menthol cigarettes | |
| US2331830A (en) | Tobacco | |
| US1555580A (en) | Process of treating cigarette tobacco | |
| KR100827820B1 (en) | Cigarette filter containing Cypress essential oil phytoncide powder and its manufacturing method | |
| US2418296A (en) | Medicated cigarette | |
| KR20010089850A (en) | Process for producing an excellent cigarrete filter whicl can be able to remove the harmful substances containg nicotine as welles as tar | |
| DE618359C (en) | Process for the production of nicotine-free tobacco products | |
| CN105595412B (en) | A kind of preparation method of gomuti palm powder extracts and its application in cigarette | |
| US1984445A (en) | Process for the expulsion of nicotine from tobacco | |
| US2164030A (en) | Process for curing plant foliage | |
| KR100828180B1 (en) | Cigarette filter containing cypress phytoncide and manufacturing method thereof | |
| US3612063A (en) | Oxidized cellulose smoking product | |
| CN111647462A (en) | Preparation method and application of michelia figo extract for cigarettes | |
| US1673216A (en) | Method of treating tobacco | |
| GB413942A (en) | Process for producing tobacco free from nicotine | |
| US318881A (en) | Joseph de susdsri | |
| JPS60248160A (en) | Tobacco additive | |
| US1888173A (en) | Method of treating tobacco leaves, process of producing alpha composition for use inthe practice of the method, and resultant composition |